Literature DB >> 17462962

Genetic diversity and major spoligotype families of drug-resistant Mycobacterium tuberculosis clinical isolates from different regions of Turkey.

Riza Durmaz1, Thierry Zozio, Selami Gunal, Akgun Yaman, Cengiz Cavusoglu, Cengiz Guney, Christophe Sola, Nalin Rastogi.   

Abstract

To highlight the transmission rate and major phylogenetic clades of drug-resistant Mycobacterium tuberculosis isolates, a total of 200 drug-resistant strains isolated in four different regions of Turkey (Marmara n=81; Mediterranean n=39; Aegean n=42; East Anatolia n=38), were typed by spoligotyping and IS6110-restriction fragment length polymorphism (RFLP). The major spoligotyping-defined shared-types (STs) and corresponding lineages were, ST 41 (22.5%, LAM7-TUR), ST53 (19.5%, ill-defined T super-family), ST 50 (6.5%, Haarlem 3), ST 1261 (4.5%, LAM7-TUR), ST 47 (3.5%, Haarlem 1), as well as two STs that belonged to undefined clades (ST 284, 3%, and ST 2067, 2.5%). The global distribution of major M. tuberculosis lineages among drug-resistant strains was as follows: T super-family (29%), Latin-American & Mediterranean (33.5%), Haarlem (14%), and the S lineage (3%). A high number of strains (n=29, 14.5%) showed patterns that did not fall within major clades described so far. A combination of spoligotyping and IS6110-RFLP fingerprinting methods resulted in a final clustering rate of 38.5% and a recent transmission rate of 25.5%. Our results underline the highly diverse nature of drug-resistant tuberculosis in our study population, as well as its ongoing transmission with lineages that are specific to these regions, the most predominant being the LAM7-TUR lineage which shows an enhanced phylogeographical specificity for Turkey.

Entities:  

Mesh:

Year:  2007        PMID: 17462962     DOI: 10.1016/j.meegid.2007.03.003

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  11 in total

1.  Integration of Mycobacterium tuberculosis drug susceptibility testing and genotyping with epidemiological data analysis to gain insight into the epidemiology of drug-resistant tuberculosis in Malatya, Turkey.

Authors:  Mansi Agarwal; Selami Gunal; Riza Durmaz; Zhenhua Yang
Journal:  J Clin Microbiol       Date:  2010-07-21       Impact factor: 5.948

2.  Molecular diversity of drug resistant mycobacterium tuberculosis strains in Western Turkey.

Authors:  Süheyla Sürücüoğlu; Selami Günal; Nuri Ozkütük; Can Biçmen; Ayşe Ozsöz; Hörü Gazi; Rıza Durmaz
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

3.  Demographic and microbial characteristics of extrapulmonary tuberculosis cases diagnosed in Malatya, Turkey, 2001-2007.

Authors:  Selami Gunal; Zhenhua Yang; Mansi Agarwal; Mehmet Koroglu; Zeynep Kazgan Arıcı; Riza Durmaz
Journal:  BMC Public Health       Date:  2011-03-08       Impact factor: 3.295

4.  Molecular epidemiology of Mycobacterium tuberculosis, Buenos Aires, Argentina.

Authors:  Ximena Gonzalo; Marta Ambroggi; Ezequiel Cordova; Tim Brown; Susana Poggi; Francis Drobniewski
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

5.  Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey.

Authors:  Ozgul Kisa; Gulnur Tarhan; Selami Gunal; Ali Albay; Riza Durmaz; Zeynep Saribas; Thierry Zozio; Alpaslan Alp; Ismail Ceyhan; Ahmet Tombak; Nalin Rastogi
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

6.  Drug-resistance profiling and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Saudi Arabia revealed by whole genome sequencing.

Authors:  Hawra Al-Ghafli; Thomas A Kohl; Matthias Merker; Bright Varghese; Anason Halees; Stefan Niemann; Sahal Al-Hajoj
Journal:  Infect Drug Resist       Date:  2018-11-12       Impact factor: 4.003

7.  Role of Molecular Epidemiology on Tuberculosis Control in the Middle East Countries: a Systematic Review and Meta-Analysis.

Authors:  Mahya Pourostadi; Jalil Rashedi; Behroz Mahdavi Poor; Hossein Samadi Kafil; Abdolhassan Kazemi; Ehsan Ahmadpour; Mohammad Asgharzadeh
Journal:  Tanaffos       Date:  2018-10

Review 8.  Prevalence and occurrence rate of Mycobacterium tuberculosis Haarlem family multi-drug resistant in the worldwide population: A systematic review and meta-analysis.

Authors:  Rashid Ramazanzadeh; Daem Roshani; Pegah Shakib; Samaneh Rouhi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

9.  Suitability of IS6110-RFLP and MIRU-VNTR for differentiating spoligotyped drug-resistant mycobacterium tuberculosis clinical isolates from Sichuan in China.

Authors:  Chao Zheng; Yuding Zhao; Guoqiang Zhu; Song Li; Honghu Sun; Qin Feng; Mei Luo; Fanzi Wu; Xuefeng Li; Véronique Hill; Nalin Rastogi; Qun Sun
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

10.  Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil.

Authors:  Flávia A D de Freitas; Vagner Bernardo; Michel K Gomgnimbou; Christophe Sola; Hélio R Siqueira; Márcia A S Pereira; Fátima C O Fandinho; Harrison M Gomes; Marcelo E I Araújo; Philip N Suffys; Elizabeth A Marques; Rodolpho M Albano
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.